Composition of the HLA-DR-associated human thymus peptidome

European Journal of Immunology

Volumn 43, Issue 9, 2013, Pages 2273-2282

  Collado, Javier A ^a   Alvarez, Iñaki ^a   Ciudad, M Teresa ^a   Espinosa, Gabriel ^a   Canals, Francesc ^b   Pujol Borrell, Ricardo ^a   Carrascal, Montserrat ^a   Abian, Joaquín ^a   Jaraquemada, Dolores ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

Author keywords

HLA DR; MHC; Proteomics; Thymic selection; Tolerance

Indexed keywords

CATHEPSIN S; CD71 ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; SERUM ALBUMIN; THYMUS PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CELL POPULATION; CONTROLLED STUDY; ELUTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; INFANT; ION TRAP MASS SPECTROMETRY; LYMPHOBLASTOID CELL LINE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SINGLE CELL ANALYSIS; T LYMPHOCYTE; THYMUS;

HLA-DR; MHC; PROTEOMICS; THYMIC SELECTION; TOLERANCE;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; PEPTIDES; PROTEOME; THYMUS GLAND;

EID: 84883497302     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243280     Document Type: Article

References (37)

1. Von Boehmer, H. and Kisielow, P., Self-nonself discrimination by T cells. Science. 1990. 248: 1369-1373.
2. Starr, T. K., Jameson, S. C. and Hogquist, K. A., Positive and negative selection of T cells. Annu. Rev. Immunol. 2003. 21: 139-176.
3. Ciofani, M. and Zúñiga-Pflücker, J. C., The thymus as an inductive site for T lymphopoiesis. Annu. Rev. Cell Dev. Biol. 2007. 23: 463-493.
4. Neefjes, J. J., Stollorz, V., Peters, P. J., Geuze, H. J. and Ploegh, H. L., The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell. 1990. 61: 171-183.
5. Ferrero, I., Anjuère, F., Martín, P., Martínez del Hoyo, G., Ĺopez Fraga, M., Wright, N., Varona, R. et al., Functional and phenotypic analysis of thymic B-cells: role in the induction of T cell negative selection. Eur. J. Immunol. 1999. 29: 1598-1609.
6. Weerkamp, F., Baert, M. R. M., Brugman, M. H., Dik, W. A., de Haas, E. F. E., Visser, T. P., de Groot, C. J. M. et al., Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential. Blood. 2006. 107: 3131-3137.
7. Rezzani, R., Bonomini, F. and Rodella, L. F., Histochemical and molecular overview of the thymus as site for T cells development. Prog. Histochem. Cytochem. 2008. 43: 73-120.
8. Kourilsky, P. and Claverie, J. M., MHC restriction, alloreactivity, and thymic education: a common link? Cell. 1989. 56: 327-329.
9. Nedjic, J., Aichinger, M., Emmerich, J., Mizushima, N. and Klein, L., Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature. 2008. 455: 396-400.
10. Klein, L., Hinterberger, M., Wirnsberger, G. and Kyewski, B., Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 2009. 9: 833-844.
11. Hadeiba, H., Lahl, K., Edalati, A., Oderup, C., Habtezion, A., Pachynski, R., Nguyen, L. et al., Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity. 2012. 36: 438-450.
12. Klein, L. and Kyewski, B., Self-antigen presentation by thymic stromal cells: a subtle division of labor. Curr. Opin. Immunol. 2000. 12: 179-186.
13. Sant, A. J., Chaves, F. A., Jenks, S. A., Richards, K. A., Menges, P., Weaver, J. M. and Lazarski, C. A., The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 2005. 207: 261-278.
14. Muixí, L., Carrascal, M., Alvarez, I., Daura, X., Martí, M., Armengol, M. P., Pinilla, C. et al., Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J. Immunol. 2008. 181: 795-807.
15. Alvarez, I., Collado, J., Daura, X., Colomé, N., Rodríguez García, M., Gallart, T., Canals, F. et al., The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB*0101) and HLA-DR4 (DRB*0401). Arthritis Rheumat. 2008. 58: 1630-1639.
16. Huang, D. W., Sherman, B. T. and Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009. 4: 44-57.
17. Muixi, L., Gay, M., Munoz-Torres, P. M., Guitart, C., Cedano, J., Abian, J., Alvarez, I. et al., The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles. Genes Immun. 2011. 12: 504-512.
18. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. and Stevanović, S., SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 1999. 50: 213-219.
19. Fissolo, N., Haag, S., de Graaf, K. L., Drews, O., Stevanovic, S., Rammensee, H. G. and Weissert, R., Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol. Cell Proteomics. 2009. 8: 2090-2101.
20. Dengjel, J., Nastke, M.-D., Gouttefangeas, C., Gitsioudis, G., Schoor, O., Altenberend, F., Müller, M. et al., Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas. Clin. Cancer Res. 2006. 12: 4163-4170.
21. Wahlström, J., Dengjel, J., Persson, B., Duyar, H., Rammensee, H.-G., Stevanoviδc, S., Eklund, A. et al., Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J. Clin. Invest. 2007. 117: 3576-3582.
22. Scollay, R. G., Butcher, E. C. and Weissman, I. L., Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur. J. Immunol. 1980. 10: 210-218.
23. Takahama, Y., Tanaka, K. and Murata, S., Modest cortex and promiscuous medulla for thymic repertoire formation. Trends Immunol. 2008. 29: 251-255.
24. Ziegler, A., Müller, C. A., Böckmann, R. A. and Uchanska-Ziegler, B., Low-affinity peptides and T-cell selection. Trends Immunol. 2009. 30: 53-60.
25. Douek, D. C. and Altmann, D. M., T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus. Immunology. 2000. 99: 249-256.
26. Muntasell, A., Carrascal, M., Alvarez, I., Serradell, L., van Veelen, P., Verreck, F. A. W., Koning, F. et al. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands. J. Immunol. 2004. 173: 1085-1093.
27. Nielsen, M., Lund, O., Buus, S. and Lundegaard, C., MHC Class II epitope predictive algorithms. Immunology. 2010; 130:319-328.
28. Levisetti, M. G., Lewis, D. M., Suri, A. and Unanue, E. R., Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Diabetes. 2008. 57: 1852-1860.
29. Suri, A., Levisetti, M. G. and Unanue, E. R., Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr. Opin. Immunol. 2008. 20: 105-110.
30. Guix, M., Pérez-López, B., Sahin, M., Roldán, M., Ambrosi, A. and Merkoçi, A., Structural characterization by confocal laser scanning microscopy and electrochemical study of multi-walled carbon nanotube tyrosinase matrix for phenol detection. Analyst. 2010. 135: 1918-1925.
31. Alvarez, I., Carrascal, M., Canals, F., Muixí, L., Abián, J. and Jaraquemada, D., Analysis of the HLA class I associated peptide repertoire in a hepatocellular carcinoma cell line reveals tumor-specific peptides as putative targets for immunotherapy. Proteomics Clin. Appl. 2007. 1: 286-298.
32. Carrascal, M., Ovelleiro, D., Casas, V., Gay, M. and Abian, J., Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment. J. Proteome Res. 2008. 7: 5167-5176.
33. Nielsen, M., Justesen, S., Lund, O., Lundegaard, C. and Buus, S., NetMHCIIpan-2.0: improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res. 2010. 6: 9-18.
34. Singh, H. and Raghava, G. P., ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001. 17: 1236-1237.
35. Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M. et al., Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 1999. 17: 555-561.
36. Novak, E. J., Liu, A. W., Nepom, G. T. and Kwok, W. W., MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 1999. 104: R63-R67.
37. Ettinger, R. A. and Kwok, W. W., A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J. Immunol. 1998. 160: 2365-2373.